Remo Moomiaie-Qajar, Cytonus Therapeutics CEO
Exclusive: San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines
Cytonus Therapeutics, a small biotech company north of San Diego, raised $11.7 million in Series A financing to engineer cells as delivery vessels for genetic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.